Consolidated Financial Results
for the Fiscal Year Ended June 20, 2021
[Japanese GAAP]
July 27, 2021
Company name: Genky DrugStores Co., Ltd.
Stock exchange listing: Tokyo Stock Exchange
Code number: 9267
URL: http://www.genkydrugstores.co.jp
Representative: Kenichi Fujinaga, President
Contact: Takeshi Tsunemi, Executive Officer, Treasurer and General Manager, IR Division
Phone: +81-776-67-5240
Scheduled date of convention of ordinary general meeting of shareholders: September 3, 2021
Scheduled date of commencing dividend payments: September 6, 2021
Scheduled date of filing annual securities report: September 6, 2021
Availability of supplementary briefing material on annual financial results: Available
Schedule of annual financial results briefing session: Scheduled (for institutional investors and analysts)
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Fiscal Year Ended June 20, 2021 (June 21, 2020 to June 20, 2021)
(1) Consolidated Operating Results | (% indicates changes from the previous corresponding period.) | |||||||||||||||||
Net income | ||||||||||||||||||
Net sales | Operating income | Ordinary income | attributable to owners | |||||||||||||||
of parent | ||||||||||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | |||||||||||
Fiscal 2020 | 142,376 | 15.2 | 6,294 | 45.0 | 6,601 | 44.6 | 4,831 | 75.4 | ||||||||||
Fiscal 2019 | 123,603 | 19.0 | 4,341 | 7.3 | 4,566 | 6.1 | 2,755 | 2.1 | ||||||||||
(Note) Comprehensive income: Fiscal 2020: ¥4,848 million (76.6%) | ||||||||||||||||||
Fiscal 2019: ¥2,745 million (2.5%) | ||||||||||||||||||
Net income | Diluted net | Net income to | Ordinary income | Operating income | ||||||||||||||
shareholders' | ||||||||||||||||||
per share | income per share | to total assets ratio | to net sales ratio | |||||||||||||||
equity ratio | ||||||||||||||||||
Yen | Yen | % | % | % | ||||||||||||||
Fiscal 2020 | 318.35 | 318.03 | 16.2 | 7.6 | 4.4 | |||||||||||||
Fiscal 2019 | 181.52 | 181.52 | 10.4 | 6.1 | 3.5 | |||||||||||||
(Reference): Equity in earnings of affiliates: Fiscal 2020: ¥― million | ||||||||||||||||||
Fiscal 2019: ¥― million | ||||||||||||||||||
(2) Consolidated Financial Position | ||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||||
Million yen | Million yen | % | Yen | |||||||||||||||
As of June 20, 2021 | 90,795 | 32,166 | 35.4 | 2,117.96 | ||||||||||||||
As of June 20, 2020 | 83,145 | 27,685 | 33.3 | 1,823.51 |
(Reference) Equity: As of June 20, 2021: ¥32,144 million As of June 20, 2020: ¥27,676 million
(3) Consolidated Cash Flows
Cash flow from | Cash flow from | Cash flow from | Cash and cash | ||||||||||||
equivalents at the end | |||||||||||||||
operating activities | investing activities | financing activities | |||||||||||||
of the fiscal year | |||||||||||||||
Million yen | Million yen | Million yen | Million yen | ||||||||||||
Fiscal 2020 | 12,075 | (8,829) | (1,953) | 7,913 | |||||||||||
Fiscal 2019 | 7,411 | (11,222) | 7,989 | 6,620 | |||||||||||
2. Dividends | |||||||||||||||
Annual dividends | Total annual | Dividend | Dividend on | ||||||||||||
payout ratio | equity ratio | ||||||||||||||
1st | 2nd | 3rd | Year-end | Total | dividends | ||||||||||
(consolidated) | (consolidated) | ||||||||||||||
quarter-end | quarter-end | quarter-end | |||||||||||||
Yen | Yen | Yen | Yen | Yen | Million yen | % | % | ||||||||
Fiscal 2019 | - | 12.50 | - | 12.50 | 25.00 | 379 | 13.8 | 1.4 | |||||||
Fiscal 2020 | - | 12.50 | - | 12.50 | 25.00 | 379 | 7.9 | 1.3 | |||||||
Fiscal 2021 | - | 12.50 | - | 12.50 | 25.00 | 8.0 | |||||||||
(Forecast) | |||||||||||||||
3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 20, 2022 (June 21, 2021 to June 20, 2022)
(% indicates changes from | the previous | fiscal year.) | ||||||||
Net income | Net income | |||||||||
Net sales | Operating income | Ordinary income | attributable to | |||||||
per share | ||||||||||
owners of parent | ||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen | ||
First half | 76,800 | - | 3,100 | (4.1) | 3,250 | (5.0) | 2,260 | (7.2) | 148.91 | |
Full year | 160,000 | - | 6,500 | 3.3 | 6,800 | 3.0 | 4,720 | (2.3) | 310.99 |
(Note) From the beginning of the fiscal year ending June 20, 2022, "Accounting Standard for Revenue Recognition" (ASBJ Statement No. 29), etc. will be applied, and the forecast is based on this standard. Therefore, the percentage of changes from the previous fiscal year in actual net sales before applying the standard is not presented.
Notes:
-
Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes in scope of consolidation): No
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name) - Changes in accounting policies, changes in accounting estimates and retrospective restatement
- Changes in accounting policies due to the revision of accounting standards: No
- Changes in accounting policies other than 1) above: No
- Changes in accounting estimates: No
- Retrospective restatement: No
- Total number of issued shares (common stock)
-
Total number of issued shares at the end of the period (including treasury stock): As of June 20, 2021: 15,477,484 shares
As of June 20, 2020: 15,477,484 shares - Total number of treasury stock at the end of the period:
As of June 20, 2021: 300,324 shares
As of June 20, 2020: 300,159 shares
- Average number of shares during the period: Year ended June 20, 2021: 15,177,219 shares Year ended June 20, 2020: 15,177,335 shares
(Reference) Summary of Non-Consolidated Financial Results
Non-Consolidated Financial Results for the Fiscal Year Ended June 20, 2021 (June 21, 2020 to June 20, 2021)
(1) Non-Consolidated Operating Results | (% indicates changes from the previous fiscal year.) | |||||||||||||||||
Net sales | Operating income | Ordinary income | Net income | |||||||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | |||||||||||
Fiscal 2020 | 318 | 18.1 | 141 | 153.1 | 220 | 193.1 | 132 | 331.6 | ||||||||||
Fiscal 2019 | 269 | 10.0 | 55 | 541.2 | 75 | 137.0 | 30 | 348.8 | ||||||||||
Net income per share | Diluted net income | |||||||||||||||||
per share | ||||||||||||||||||
Yen | Yen | |||||||||||||||||
Fiscal 2020 | 8.71 | 8.70 | ||||||||||||||||
Fiscal 2019 | 2.02 | 2.02 | ||||||||||||||||
(2) Non-Consolidated Financial Position | ||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||||
Million yen | Million yen | % | Yen | |||||||||||||||
As of June 20, 2021 | 23,260 | 21,343 | 91.7 | 1,404.84 | ||||||||||||||
As of June 20, 2020 | 23,092 | 21,578 | 93.4 | 1,421.16 |
(Reference) Equity: As of June 20, 2021: ¥21,321 million As of June 20, 2020: ¥21,569 million
- These financial results are outside the scope of audit by a certified public accountant or an audit corporation.
- Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors.
Attachments
- Original document
- Permalink
Disclaimer
Genky DrugStores Co. Ltd. published this content on 27 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2021 06:09:05 UTC.